Vital cancer drug administered fast MSN NZ News Patients diagnosed with follicular non-Hodgkin lymphoma (NHL), a disease that attacks one specific type of infection-fighting cell, previously had rituximab administered via an intravenous drip. But the trial at Southampton General Hospital can now ... |
